Given that both AOD 9604 and tirzepatide protocols typically run for months, the cumulative investment is a practical consideration that should factor into the decision
But it is kind of a consistent trend line where were seeing more studies come out and show the same thing, same thing
And as it does, a picture is emerging that looks very familiar to practitioners of functional and integrative medicineone defined by viral persistence, mitochondrial dysfunction, chronic inflammation, immune dysregulation, microbiome disruption, and autonomic nervous system damage
What BPC-157 is BPC-157 is a synthetic pentadecapeptide, fifteen amino acids long, originally derived from a partial sequence of a larger protein identified in human gastric juice (the body-protection compound, or BPC)
It was developed in Russia and is studied mainly as an anxiolytic (anti-anxiety) and anti-asthenic agent
Severe deficiency may lead to anaemia or nerve damage